Opus Genetics, Stock Market Value
| IRD Stock | 1.15 0.04 3.60% |
| Symbol | Opus |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opus Genetics,. If investors know Opus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opus Genetics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Opus Genetics, is measured differently than its book value, which is the value of Opus that is recorded on the company's balance sheet. Investors also form their own opinion of Opus Genetics,'s value that differs from its market value or its book value, called intrinsic value, which is Opus Genetics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opus Genetics,'s market value can be influenced by many factors that don't directly affect Opus Genetics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Opus Genetics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Opus Genetics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Opus Genetics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Opus Genetics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Opus Genetics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Opus Genetics,.
| 12/08/2023 |
| 12/02/2024 |
If you would invest 0.00 in Opus Genetics, on December 8, 2023 and sell it all today you would earn a total of 0.00 from holding Opus Genetics, or generate 0.0% return on investment in Opus Genetics, over 360 days. Opus Genetics, is related to or competes with Vincerx Pharma, Viracta Therapeutics, Dogwood Therapeutics,, Viking Therapeutics, Dyadic International, Vanda Pharmaceuticals, and Viridian Therapeutics. Opus Genetics, is entity of United States More
Opus Genetics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Opus Genetics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Opus Genetics, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 29.54 | |||
| Value At Risk | (6.02) | |||
| Potential Upside | 8.91 |
Opus Genetics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Opus Genetics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Opus Genetics,'s standard deviation. In reality, there are many statistical measures that can use Opus Genetics, historical prices to predict the future Opus Genetics,'s volatility.| Risk Adjusted Performance | 0.0029 | |||
| Jensen Alpha | (0.34) | |||
| Total Risk Alpha | (0.83) | |||
| Treynor Ratio | (0.02) |
Opus Genetics, Backtested Returns
At this point, Opus Genetics, is extremely dangerous. Opus Genetics, maintains Sharpe Ratio (i.e., Efficiency) of 0.0122, which implies the firm had a 0.0122% return per unit of risk over the last 3 months. We have found twenty-two technical indicators for Opus Genetics,, which you can use to evaluate the volatility of the company. Please check Opus Genetics,'s Variance of 22.27, risk adjusted performance of 0.0029, and Coefficient Of Variation of (13,981) to confirm if the risk estimate we provide is consistent with the expected return of 0.0581%. The company holds a Beta of 2.35, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Opus Genetics, will likely underperform. Opus Genetics, right now holds a risk of 4.77%. Please check Opus Genetics, treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day median price , to decide if Opus Genetics, will be following its historical price patterns.
Auto-correlation | 0.73 |
Good predictability
Opus Genetics, has good predictability. Overlapping area represents the amount of predictability between Opus Genetics, time series from 8th of December 2023 to 5th of June 2024 and 5th of June 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Opus Genetics, price movement. The serial correlation of 0.73 indicates that around 73.0% of current Opus Genetics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.73 | |
| Spearman Rank Test | 0.76 | |
| Residual Average | 0.0 | |
| Price Variance | 0.09 |
Opus Genetics, lagged returns against current returns
Autocorrelation, which is Opus Genetics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Opus Genetics,'s stock expected returns. We can calculate the autocorrelation of Opus Genetics, returns to help us make a trade decision. For example, suppose you find that Opus Genetics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Opus Genetics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Opus Genetics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Opus Genetics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Opus Genetics, stock over time.
Current vs Lagged Prices |
| Timeline |
Opus Genetics, Lagged Returns
When evaluating Opus Genetics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Opus Genetics, stock have on its future price. Opus Genetics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Opus Genetics, autocorrelation shows the relationship between Opus Genetics, stock current value and its past values and can show if there is a momentum factor associated with investing in Opus Genetics,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Opus Genetics, is a strong investment it is important to analyze Opus Genetics,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Opus Genetics,'s future performance. For an informed investment choice regarding Opus Stock, refer to the following important reports:Check out Opus Genetics, Correlation, Opus Genetics, Volatility and Opus Genetics, Alpha and Beta module to complement your research on Opus Genetics,. For information on how to trade Opus Stock refer to our How to Trade Opus Stock guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Opus Genetics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.